Samsara BioCapital’s Equillium EQ Stock Holding History

Samsara BioCapital’s Portfolio EQ Stock Details EQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-615,541	Closed	-$449K	–	50
2023 Q1	$449K	Hold	615,541	–	–	0.09%	43
2022 Q4	$652K	Hold	615,541	–	–	0.14%	41
2022 Q3	$1.37M	Hold	615,541	–	–	0.32%	41
2022 Q2	$1.26M	Hold	615,541	–	–	0.33%	40
2022 Q1	$1.94M	Hold	615,541	–	–	0.49%	41
2021 Q4	$2.32M	Sell	615,541 -122,635	-17%	-$663K	0.45%	34
2021 Q3	$5.03M	Hold	738,176	–	–	0.79%	28
2021 Q2	$4.35M	Sell	738,176 -26,227	-3%	-$165K	0.54%	30
2021 Q1	$5.46M	Sell	764,403 -309,882	-29%	-$2.22M	1.01%	24
2020 Q4	$5.75K	Hold	1,074,285	–	–	0.58%	19
2020 Q3	$6.2M	Buy	+1,074,285	New	+$8.7M	1.73%	15

Other funds holding EQ

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cota Capital Management San Francisco, California $177K AUM 63.94% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Samsara BioCapital's EQ Position: Q2 2023 in Review

Samsara BioCapital sold out of Equillium (EQ) in Q2 2023, closing a stake of 615,541 shares — an estimated $449K sold.

Samsara BioCapital first reported a position in EQ in Q3 2020 and held it in 11 quarters. The position peaked at $6.2M in Q3 2020. 27 funds tracked by Wall St. Rank hold EQ as of Q2 2023.

Samsara BioCapital reported no remaining Equillium position as of Q2 2023 after selling out during the quarter.
Samsara BioCapital sold 615,541 Equillium shares in Q2 2023, an estimated $449K.
Samsara BioCapital first reported a position in Equillium in Q3 2020 and held it in 11 quarters.
Samsara BioCapital's Equillium position peaked at $6.2M in Q3 2020.
27 funds tracked by Wall St. Rank held Equillium as of Q2 2023.

Based on Samsara BioCapital's 13F filing for Q2 2023, filed 14 Aug 2023.